Pulmonary embolism - Nursing Case Study
Pathophysiology
• Primary mechanism: A pulmonary embolism (PE) occurs when a blood clot, often originating from a deep vein thrombosis (DVT) in the legs, travels through the bloodstream and becomes lodged in the pulmonary arteries, obstructing blood flow to the lung tissue and causing ventilation-perfusion mismatch.
• Secondary mechanism: The obstruction leads to increased pulmonary vascular resistance, which can cause right ventricular strain or failure due to the heart working harder to push blood into the lungs against the elevated pressure, compromising cardiac output and leading to hypoxemia.
• Key complication: If untreated, PE can lead to severe complications such as pulmonary infarction, where the lung tissue dies due to lack of blood supply, or systemic hypotension due to impaired cardiac function, both of which can be life-threatening.
Patient Profile
Demographics:
45-year-old female, office manager
History:
• Key past medical history: Hypertension, Deep Vein Thrombosis (DVT) 2 years ago
• Current medications: Lisinopril, Warfarin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Sudden onset of shortness of breath and chest pain
• Key symptoms: Dyspnea, pleuritic chest pain, hemoptysis, lightheadedness
• Vital signs: Blood pressure 145/95 mmHg, heart rate 110 bpm, respiratory rate 28 breaths per minute, oxygen saturation 88% on room air, temperature 37.2°C (99°F)
Section 1
As the initial assessment proceeds, the healthcare team notes further critical findings. The patient, now placed on supplemental oxygen, shows slight improvement in her oxygen saturation, which rises to 92%. However, her respiratory rate remains elevated at 26 breaths per minute, indicating persistent respiratory distress. Auscultation of the lungs reveals diminished breath sounds in the right lower lobe, raising suspicion of a potential secondary complication such as pulmonary infarction. Additionally, an ECG performed reveals signs of right heart strain, including S1Q3T3 pattern, which corroborates the suspicion of a significant pulmonary embolism affecting hemodynamic stability.
Laboratory tests provide further insight into the patient's condition. An elevated D-dimer level of 1.5 mcg/mL suggests ongoing thrombotic activity, and arterial blood gas analysis shows a pH of 7.34, PaCO2 of 48 mmHg, and PaO2 of 60 mmHg, indicating respiratory acidosis with hypoxemia. These findings prompt the decision to initiate anticoagulation therapy with intravenous heparin to prevent further clot propagation. Meanwhile, a CT pulmonary angiogram is ordered to confirm the diagnosis and assess the extent of the embolic burden.
As the team awaits imaging results, the patient suddenly reports an increase in chest discomfort accompanied by a sense of impending doom, a classic sign of worsening PE or potential cardiac compromise. Her blood pressure drops to 90/60 mmHg, and heart rate escalates to 125 bpm, signifying a decrease in cardiac output and potential onset of obstructive shock. This acute change necessitates rapid clinical reasoning to prioritize interventions such as fluid resuscitation and consideration of advanced therapies, including thrombolytics, to restore hemodynamic stability and prevent further deterioration. The unfolding scenario highlights the need for continuous monitoring and swift adaptation of treatment strategies in response to evolving clinical cues.
Section 2
As the healthcare team assesses the patient's acute change in status, they quickly prioritize interventions to stabilize her condition. Fluid resuscitation is initiated with a rapid infusion of normal saline to support blood pressure, while careful monitoring of her hemodynamic status ensues. Despite these efforts, the patient's blood pressure remains marginally stable at 92/65 mmHg, and her heart rate continues to be elevated at 120 bpm. The team recognizes the potential need for more aggressive intervention and begins preparing for the possible administration of thrombolytic therapy, weighing the risks and benefits given the severity of her presentation.
Meanwhile, the CT pulmonary angiogram results return, revealing extensive bilateral pulmonary emboli with significant obstruction in the right pulmonary artery, correlating with the noted diminished breath sounds in the right lower lobe. This finding confirms the suspicion of a large embolic burden contributing to her hemodynamic instability. The decision is made to initiate thrombolytic therapy with alteplase to dissolve the clots and improve pulmonary circulation, recognizing that timely intervention is critical in preventing further cardiac compromise.
As thrombolytic therapy is underway, the patient's respiratory status is closely monitored. Her oxygen saturation shows slight improvement, now rising to 94% with supplemental oxygen, and her respiratory rate decreases to 22 breaths per minute, indicating a modest alleviation of respiratory distress. However, the team remains vigilant for potential complications of thrombolytic therapy, such as bleeding, and continues to assess for any signs of improvement or deterioration. The unfolding scenario emphasizes the need for dynamic clinical reasoning, as the team must continuously adapt their management plan in response to the patient's evolving condition while preparing for possible complications and the next steps in her care journey.
Section 3
As the team continues to monitor the patient, a sudden change in her neurological status raises concerns. The patient becomes increasingly lethargic and difficult to arouse, prompting a rapid bedside neurological assessment. Her pupils are equal but sluggishly reactive to light, and she exhibits a new-onset right-sided weakness. These findings suggest the possibility of an intracranial event, a known complication of thrombolytic therapy, necessitating immediate further investigation.
A stat head CT is ordered and reveals a small intracerebral hemorrhage, likely secondary to the recent administration of alteplase. The healthcare team quickly convenes to reassess the risk-benefit balance of continuing thrombolytic therapy in light of this new complication. The decision is made to halt the thrombolytic infusion to minimize further bleeding risk while consulting neurology for guidance on managing the hemorrhage.
The patient's vital signs remain marginally stable, with blood pressure at 90/60 mmHg and heart rate at 115 bpm. Close monitoring of her neurological status is prioritized, and a plan is developed to carefully titrate supportive measures such as blood pressure control to avoid exacerbating the intracerebral bleed. The team also considers initiating anticoagulant reversal agents if clinically indicated. This new complication requires a shift in clinical reasoning as the team balances treating the pulmonary embolism with mitigating the risk of further neurological compromise. The patient's care plan is adjusted accordingly, with a focus on stabilizing her condition and preventing additional complications while maintaining a multidisciplinary approach to her evolving clinical picture.
Section 4
As the healthcare team continues to monitor the patient, they notice subtle but significant changes in her clinical status. Her blood pressure, previously marginally stable, begins to decline, now reading 85/55 mmHg, with the heart rate increasing to 120 bpm—a concerning sign of potential hemodynamic instability. In response, the team institutes careful fluid resuscitation, opting for isotonic crystalloids to support her blood pressure without risking fluid overload. Despite these efforts, the patient's oxygen saturation remains slightly reduced at 92% on 2 liters of nasal cannula, prompting an increase in supplemental oxygen.
The patient also exhibits increased respiratory effort, characterized by mild tachypnea at 24 breaths per minute, which prompts further assessment for potential respiratory complications secondary to the pulmonary embolism. An arterial blood gas analysis reveals a mild respiratory alkalosis with a pH of 7.48 and a PaCO2 of 33 mmHg, indicating that her body is compensating for the underlying hypoxemia. These findings necessitate a reevaluation of her respiratory management strategy, emphasizing the need for potential escalation to non-invasive ventilation if her condition does not stabilize.
Concurrent with these interventions, the team reviews recent laboratory results that indicate a drop in hemoglobin to 10.2 g/dL, raising concerns about potential ongoing or new bleeding. The decision is made to continue close hematological monitoring and consider the cautious administration of packed red blood cells if her hemoglobin continues to decline, balancing the risks of transfusion with the need to optimize oxygen delivery to her tissues. Throughout this process, the healthcare team remains vigilant, continuously reassessing the patient's response to interventions and updating the care plan as needed to address her complex, evolving condition.
Section 5
As the healthcare team continues to manage the patient, new diagnostic results shed light on the complexities of her condition. A follow-up chest CT angiogram reveals an expansion of the thrombus burden in the right pulmonary artery, suggesting a progression of the pulmonary embolism despite anticoagulation therapy. This finding raises significant concerns about the effectiveness of the current treatment regimen and the potential need for alternative therapies, such as thrombolysis or surgical intervention, to prevent further hemodynamic compromise.
In addition to the imaging results, repeat laboratory evaluations show a further decline in hemoglobin levels to 9.5 g/dL, intensifying the concern for potential internal bleeding. The team considers the possibility of gastrointestinal bleeding as a complication of anticoagulation, prompting an urgent consult with gastroenterology. Meanwhile, the patient's coagulation profile remains within therapeutic range, which complicates the decision-making process regarding the continuation of anticoagulation therapy versus the risk of exacerbating any underlying bleeding source.
Clinically, the patient's status continues to evolve, with her blood pressure stabilizing slightly at 90/60 mmHg following fluid resuscitation, yet her oxygenation remains precarious. Her oxygen saturation holds at 94% after increasing supplemental oxygen to 4 liters via nasal cannula. However, the increased respiratory effort persists, and her respiratory rate escalates to 26 breaths per minute. This prompts the team to initiate bilevel positive airway pressure (BiPAP) to alleviate respiratory muscle fatigue and improve gas exchange, as they work to address the dual challenges of maintaining adequate perfusion and optimizing ventilation. These developments demand ongoing assessment and adjustment of the care plan to navigate the intricate balance between therapeutic interventions and the patient's dynamic physiological responses.